Found: 14
Select item for more details and to access through your institution.
Digital Droplet PCR is a Specific and Sensitive Tool for Detecting IDH2 Mutations in Acute Myeloid LeuKemia Patients.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1738, doi. 10.3390/cancers12071738
- By:
- Publication type:
- Article
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia.
- Published in:
- Frontiers in Pharmacology, 2016, v. 7, p. 1, doi. 10.3389/fphar.2016.00363
- By:
- Publication type:
- Article
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00528
- By:
- Publication type:
- Article
The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00532
- By:
- Publication type:
- Article
Reduced circulating B-lymphocytes and altered B-cell compartments in patients suffering from chronic myeloid leukaemia undergoing therapy with Imatinib.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 6, p. 1305, doi. 10.3390/diagnostics12061305
- By:
- Publication type:
- Article
The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00413
- By:
- Publication type:
- Article
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study.
- Published in:
- Journal of Hematology & Oncology, 2012, v. 5, n. 1, p. 53, doi. 10.1186/1756-8722-5-53
- By:
- Publication type:
- Article
WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Platelet-derived growth factor beta receptor ( PDGFRB) gene is rearranged in a significant percentage of myelodysplastic syndromes with normal karyotype.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients.
- Published in:
- British Journal of Haematology, 2003, v. 120, n. 3, p. 405, doi. 10.1046/j.1365-2141.2003.04106.x
- By:
- Publication type:
- Article
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01428
- By:
- Publication type:
- Article
The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients.
- Published in:
- Cancer Cell International, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12935-019-0807-0
- By:
- Publication type:
- Article